1.
Bioorg Med Chem Lett
; 16(21): 5633-8, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16934457
RESUMO
A new class of pyrimidine-based Janus tyrosine kinase 3 (JAK3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK3.
